Dresner-Pollak R - Search Results

1

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.

Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL. Rosen HN, et al. Calcif Tissue Int. 1994 Jan;54(1):26-9. doi: 10.1007/BF00316285. Calcif Tissue Int. 1994. PMID: 8118749 Clinical Trial.

2

Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.

Rosen HN, Sullivan EK, Middlebrooks VL, Zeind AJ, Gundberg C, Dresner-Pollak R, Maitland LA, Hock JM, Moses AC, Greenspan SL. Rosen HN, et al. J Bone Miner Res. 1993 Oct;8(10):1255-61. doi: 10.1002/jbmr.5650081014. J Bone Miner Res. 1993. PMID: 8256663

3

Biochemical markers of bone turnover reflect femoral bone loss in elderly women.

Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL. Dresner-Pollak R, et al. Calcif Tissue Int. 1996 Nov;59(5):328-33. doi: 10.1007/s002239900135. Calcif Tissue Int. 1996. PMID: 8849397

4

Diurnal variation of bone mineral turnover in elderly men and women.

Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L. Greenspan SL, et al. Calcif Tissue Int. 1997 May;60(5):419-23. doi: 10.1007/s002239900256. Calcif Tissue Int. 1997. PMID: 9115158

5

Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.

Dresner-Pollak R, Rosenblatt M. Dresner-Pollak R, et al. J Cell Biochem. 1994 Nov;56(3):323-30. doi: 10.1002/jcb.240560308. J Cell Biochem. 1994. PMID: 7876325 Review.

6

Approach to discovering novel therapeutic agents for osteoporosis based on integrin receptor blockade.

Chorev M, Dresner-Pollak R, Eshel Y, Rosenblatt M. Chorev M, et al. Biopolymers. 1995;37(6):367-75. doi: 10.1002/bip.360370603. Biopolymers. 1995. PMID: 8589242 Review.

7

Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18,D-Trp12,Tyr34]bPTH(7-34)NH2.

Dresner-Pollak R, Yang QM, Behar V, Nakamoto C, Chorev M, Rosenblatt M. Dresner-Pollak R, et al. J Bone Miner Res. 1996 Aug;11(8):1061-5. doi: 10.1002/jbmr.5650110804. J Bone Miner Res. 1996. PMID: 8854241

8

Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.

Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D. Dresner-Pollak R, et al. Am J Gastroenterol. 2000 Mar;95(3):699-704. doi: 10.1111/j.1572-0241.2000.01850.x. Am J Gastroenterol. 2000. PMID: 10710060

9

The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women.

Dresner-Pollak R, Mayer M, Hochner-Celiniker D. Dresner-Pollak R, et al. Calcif Tissue Int. 2000 Feb;66(2):104-7. doi: 10.1007/s002230010022. Calcif Tissue Int. 2000. PMID: 10652956 Clinical Trial.

10

Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture.

El-Haj M, Gurt I, Cohen-Kfir E, Dixit V, Artsi H, Kandel L, Yakubovsky O, Safran O, Dresner-Pollak R. El-Haj M, et al. Osteoporos Int. 2016 Jul;27(7):2373-2378. doi: 10.1007/s00198-016-3536-4. Epub 2016 Feb 22. Osteoporos Int. 2016. PMID: 26902093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters